Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents.
作者信息
Oliveira Eduardo A, Oliveira Maria Christina L, Silva Ana Cristina Simões E, Colosimo Enrico A, Mak Robert H, Vasconcelos Mariana A, Silva Ludmila R, Martelli Daniella B, Pinhati Clara C, Martelli-Júnior Hercílio
机构信息
Department of Pediatrics, Health Sciences Postgraduate Program, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Department of Statistics, Federal University of Minas Gerais, Belo Horizonte, Brazil.
出版信息
Pediatr Infect Dis J. 2023 Mar 1;42(3):218-225. doi: 10.1097/INF.0000000000003783. Epub 2022 Nov 29.
Abstract
摘要
相似文献
1
Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents.
Pediatr Infect Dis J. 2023 Mar 1;42(3):218-225. doi: 10.1097/INF.0000000000003783. Epub 2022 Nov 29.
2
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
3
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
4
Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
Lancet Child Adolesc Health. 2022 May;6(5):294-302. doi: 10.1016/S2352-4642(22)00027-X. Epub 2022 Feb 18.
5
Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study.
J Pediatr. 2023 Feb;253:189-196.e2. doi: 10.1016/j.jpeds.2022.09.039. Epub 2022 Sep 29.
6
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study.
Lancet Infect Dis. 2023 Jan;23(1):67-73. doi: 10.1016/S1473-3099(22)00527-8. Epub 2022 Sep 9.
7
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.
PLoS One. 2023 Mar 31;18(3):e0283715. doi: 10.1371/journal.pone.0283715. eCollection 2023.
8
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
BMC Med. 2022 Nov 23;20(1):451. doi: 10.1186/s12916-022-02655-z.
9
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
10
Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
J Med Virol. 2023 Mar;95(3):e28582. doi: 10.1002/jmv.28582.
引用本文的文献
1
Comparative performance of twelve machine learning models in predicting COVID-19 mortality risk in children: a population-based retrospective cohort study in Brazil.
PeerJ Comput Sci. 2025 May 28;11:e2916. doi: 10.7717/peerj-cs.2916. eCollection 2025.
2
Six clinical phenotypes with prognostic implications were identified by unsupervised machine learning in children and adolescents with SARS-CoV-2 infection: results from a German nationwide registry.
Respir Res. 2024 Oct 30;25(1):392. doi: 10.1186/s12931-024-03018-3.
3
Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Front Immunol. 2024 Mar 26;15:1354786. doi: 10.3389/fimmu.2024.1354786. eCollection 2024.
4
Epidemiology of the SARS-CoV-2 Omicron Variant Emergence in the Southeast Brazilian Population.
Microorganisms. 2024 Feb 23;12(3):449. doi: 10.3390/microorganisms12030449.
5
Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil.
JAMA Pediatr. 2023 Jul 31;177(10):1100-2. doi: 10.1001/jamapediatrics.2023.2584.
Zotero 插件